CBio combines novel separation science, portable microcopy, machine learning, and IoT cloud connectivity to bring unparalleled analytics to groups studying cell and microbial behavior for decision making.

About CBio

cellPhoresis®, enables non-destructive and rapid high resolution nanoscale bioAnalysis. cellPhoresis® in action: Field Based Infrastructure Management for Microbial Induced Corrosion, Non-Destructive Assessment of Vaccine Viability, Quality Testing of Microbial Ingredients for Food and Beverage (Yeast, Bacteria) to Predict Spoilage and Prevent Waste.

Tagged with

Problem statement

Existing tools to analyze microbes is costly, slow, and kills the microbes during the test. cBio bring a non-destructive, cost efficiency, and sensitive testing machine to the market.

Traction information

Patented technology. 30 peer-reviewed publication. Performed 1 pilot with a CleanTech company, FREDSense®. Pilot setup with Merck that will begin in Q1 of 2020. Letter of Support from Thermo Fisher Scientific citing the value of our product.


Profile created.
Added almost 3 years ago
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.